ZA991745B - Combination of a selective NMDA NR2B antagonist and an opioid analgesic. - Google Patents

Combination of a selective NMDA NR2B antagonist and an opioid analgesic.

Info

Publication number
ZA991745B
ZA991745B ZA9901745A ZA991745A ZA991745B ZA 991745 B ZA991745 B ZA 991745B ZA 9901745 A ZA9901745 A ZA 9901745A ZA 991745 A ZA991745 A ZA 991745A ZA 991745 B ZA991745 B ZA 991745B
Authority
ZA
South Africa
Prior art keywords
combination
opioid analgesic
selective nmda
nr2b antagonist
nmda nr2b
Prior art date
Application number
ZA9901745A
Other languages
English (en)
Inventor
Susan Boyce
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Publication of ZA991745B publication Critical patent/ZA991745B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA9901745A 1998-03-06 1999-03-04 Combination of a selective NMDA NR2B antagonist and an opioid analgesic. ZA991745B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9804885.3A GB9804885D0 (en) 1998-03-06 1998-03-06 Therapeutic combination

Publications (1)

Publication Number Publication Date
ZA991745B true ZA991745B (en) 1999-09-06

Family

ID=10828172

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9901745A ZA991745B (en) 1998-03-06 1999-03-04 Combination of a selective NMDA NR2B antagonist and an opioid analgesic.

Country Status (8)

Country Link
US (1) US6538008B1 (fr)
EP (1) EP1059923A1 (fr)
JP (1) JP2002505287A (fr)
AU (1) AU3260099A (fr)
CA (1) CA2321685A1 (fr)
GB (1) GB9804885D0 (fr)
WO (1) WO1999044610A1 (fr)
ZA (1) ZA991745B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5900420A (en) * 1997-06-19 1999-05-04 Cole; William L. Method for treating chronic fatigue syndrome and fibromyalgia with buprenorphine
CA2370030C (fr) 1999-04-09 2007-08-14 Euro-Celtique S.A. Composition de blocage du canal sodique et leur utilisation
WO2001052851A1 (fr) * 2000-01-22 2001-07-26 Albert Shulman Methodes de traitement d'abus de substances
EP1186303A3 (fr) * 2000-09-06 2003-12-10 Pfizer Products Inc. Combinaisons pharmaceutiques pour le traitement des accidents cerebrovasculaires, contenant un facteur inhibitant la neutrophile et un antagoniste selectif du NMDA-NR2B
EP1674087A1 (fr) * 2000-10-02 2006-06-28 Pfizer Products Inc. Utilisation prophylactique d'antagonistes des récepteurs du N-méthyl-D-aspartate (NMDA)
IL145584A0 (en) 2000-10-02 2002-06-30 Pfizer Prod Inc Nmda nr2b antagonists for treatment
ZA200108038B (en) * 2000-10-02 2003-04-01 Pfizer Prod Inc Prophylactic use of n-methyl-d-asparrate (NMDA) antagonists.
WO2002100352A2 (fr) * 2001-06-12 2002-12-19 Merck & Co., Inc. Antagonistes du recepteur nr2b pour le traitement ou la prevention de migraines
US8084447B2 (en) 2001-09-03 2011-12-27 Newron Pharmaceuticals S.P.A. Pharmaceutical composition comprising gabapentin or an analogue thereof and an α-aminoamide and its analgesic use
CA2486075A1 (fr) * 2002-05-13 2003-11-20 Endo Pharmaceuticals Inc. Forme pharmaceutique solide opioide a l'epreuve des abus d'opioides
WO2004022002A2 (fr) * 2002-09-09 2004-03-18 Endo Pharmaceuticals Inc. Composition analgesique combinee a liberation immediate et prolongee
US6864271B2 (en) * 2002-11-12 2005-03-08 The Foundation For The Lsu Health Sciences Center Synergistic combinations including N-acylated 4-hydroxyphenylamine derivatives
AU2004285329A1 (en) * 2003-10-21 2005-05-12 Arakis Ltd. The use of ifenprodil in the treatment of pain
JP2007509115A (ja) * 2003-10-21 2007-04-12 ソセイ・アール・アンド・ディー・リミテッド オピエートの増強のための非オピエートの使用
AU2005224160A1 (en) * 2004-03-17 2005-09-29 Sosei R&D Ltd. The treatment of inflammatory disorders and pain using beta-aminoalcohols
KR20070007850A (ko) * 2004-04-29 2007-01-16 콜드웰 갤러, 인코포레이티드 국소용 메타돈 조성물 및 그의 사용 방법
JP5225092B2 (ja) * 2005-10-14 2013-07-03 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ チピファルニブの新規ｉｖ調合物
HUP0600810A3 (en) * 2006-10-27 2008-09-29 Richter Gedeon Nyrt New sulfonamide derivatives as bradykinin antagonists, process and intermediates for their preparation and pharmaceutical compositions containing them
HUP0600808A3 (en) * 2006-10-27 2008-09-29 Richter Gedeon Nyrt New benzamide derivatives as bradykinin antagonists, process for their preparation and pharmaceutical compositions containing them
HUP0600809A3 (en) * 2006-10-27 2008-09-29 Richter Gedeon Nyrt New phenylsulfamoyl-benzamide derivatives as bradykinin antagonists, process and intermediates for their preparation and pharmaceutical compositions containing them
CN101842350A (zh) * 2007-10-27 2010-09-22 吉瑞工厂 作为缓激肽b1拮抗剂的新的非肽衍生物
MX2011000629A (es) 2008-07-17 2011-04-26 Merial Ltd Formulaciones analgesicas inyectables de larga duracion para animales.
US20110190347A1 (en) * 2008-08-21 2011-08-04 Richter Gedeon Nyrt. Methods for treating neuropathic pain
AU2009282822A1 (en) * 2008-08-21 2010-02-25 Richter Gedeon Nyrt. Methods for treating CNS disorders

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5733M (fr) 1966-09-27 1968-01-22
FR2534580A1 (fr) 1982-10-13 1984-04-20 Synthelabo Derives de phenyl-1 piperidino-2 propanol, leur preparation, et medicaments qui les contiennent
FR2628740B3 (fr) 1989-04-12 1990-01-19 Synthelabo Procede de preparation des enantiomeres du (chloro-4 phenyl)-1 (((fluoro-4 phenyl)methyl)-4 piperidyl-1)-2 ethanol
TW281670B (fr) 1993-09-02 1996-07-21 Hoffmann La Roche
US5489717A (en) * 1994-07-08 1996-02-06 Warner-Lambert Company Glutamate (NMDA) receptor antagonists
GB9520444D0 (en) 1995-10-06 1995-12-06 Pharmacia Spa Disubstituted piperidine derivatives
TW450807B (en) 1995-09-15 2001-08-21 Pfizer Pharmaceutical compositions for treating tinnitus comprising neuroprotective agents
AUPN605795A0 (en) * 1995-10-19 1995-11-09 F.H. Faulding & Co. Limited Analgesic pharmaceutical composition
ZA9610738B (en) * 1995-12-22 1997-06-24 Warner Lambert Co Subtype selective nmda receptor ligands and the use thereof

Also Published As

Publication number Publication date
JP2002505287A (ja) 2002-02-19
CA2321685A1 (fr) 1999-09-10
US6538008B1 (en) 2003-03-25
GB9804885D0 (en) 1998-04-29
EP1059923A1 (fr) 2000-12-20
AU3260099A (en) 1999-09-20
WO1999044610A1 (fr) 1999-09-10

Similar Documents

Publication Publication Date Title
ZA991745B (en) Combination of a selective NMDA NR2B antagonist and an opioid analgesic.
AU3080499A (en) Analgesic combination comprising nmda receptor antagonists and narcotic analgesics
AP2002002617A0 (en) Tamper-resistant oral opioid agonist formulation
SG104919A1 (en) Method ot form, and structure of, a dual damascene interconnect device
PL344407A1 (en) Il-2 selective agonists and antagonists
HK1060429A1 (en) A sensibility generator and the method thereof
HK1124339A1 (en) 20-keto-11beta-arylsteroids and their derivatives having agonist or antagonist hormonal activity 20--11-
HK1045308A1 (zh) 選擇性神經激肽拮抗物
HUP0100310A3 (en) A method of preventing abuse of opioid dosage forms
AU2001261144A1 (en) Ultrasonic dosage device and method
HUP0105043A2 (en) Medicinal formulations containing an opioid and an alpha-antagonist
IL137990A0 (en) A pharmaceutical preparation comprising an angiotensin ii type 2 receptor agonist, and use thereof
AU2161599A (en) Pharmaceutical combination with analgesic activity, containing an adenosinergic agonist and a compound selected from opiates, benzodiazepines and nmda antagonists
HUP0101546A3 (en) Combination for the treatment of alcohol and drug dependence containing an opioid antagonist and a nmda receptor complex modulator
IL138576A0 (en) A novel interleukin-1 receptor antagonist and uses thereof
EP1242074A4 (fr) Antagonistes de nmda/nr2b a base de 5-benzyl-octahydroindole et de 6-benzyl-decahydroquinoline
EP1190146A4 (fr) Systeme et procede d'ossature murale a poteaux faisant appel a un dispositif de raccordement et d'ecartement combine
AU7133098A (en) Kappa opioid agonists
EP1164994A4 (fr) Agonistes d'opioide sous forme de dosage a dispersion rapide
ZA987810B (en) A combination of a selective 5HT1A antagonist and a selective h5-HT1B antagonist or partial agonist
AU6878298A (en) Peripherally selective kappa opioid agonists
HU0002979D0 (en) Estrogen agonists and antagonists for multiple indications
GB2376300B (en) Acoustic mixing and measurement systems and method
ZA200203312B (en) Vasopressin antagonist formulation and process.
MXPA01011765A (es) Procedimiento y dispositivo de deteccion de utilizacion no autorizada de linea telefonica.